{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T11:48:16Z","timestamp":1792324096536,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jconrel.2025.114401","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T21:57:54Z","timestamp":1763762274000},"page":"114401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Predicting human subcutaneous bioavailability of monoclonal antibodies using an open flow microperfusion porcine model"],"prefix":"10.1016","volume":"389","author":[{"given":"Gerd","family":"Schwagerle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo Hernandes","family":"Bonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikolaj","family":"Milewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Sanchez-Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiven","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoutar","family":"Abbou Oucherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Kai","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Wiltschko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma I.","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Van Daele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Antoine","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunatha","family":"Shivaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Birngruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Venczel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114401_bb0005","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jconrel.2021.06.038","article-title":"Impact of injection sites on clinical pharmacokinetics of subcutaneously administered peptides and proteins","volume":"336","author":"Zou","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114401_bb0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40259-023-00626-1","article-title":"Advancing subcutaneous dosing regimens for biotherapeutics: clinical strategies for expedited market access","volume":"38","author":"Bittner","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.jconrel.2025.114401_bb0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.addr.2020.05.009","article-title":"Predicting bioavailability of monoclonal antibodies after subcutaneous administration: open innovation challenge","volume":"167","author":"S\u00e1nchez-F\u00e9lix","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114401_bb0020","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/17425247.2024.2403469","article-title":"Development of in vitro biopharmaceutics tools for predicting the bioavailability of subcutaneously injected monoclonal antibodies and oligonucleotides","volume":"21","author":"Somby","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.114401_bb0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2020.02.036","article-title":"Accelerating the development of novel technologies and tools for the subcutaneous delivery of biotherapeutics","volume":"321","author":"Collins","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114401_bb0030","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2020.1770028","article-title":"Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies","volume":"12","author":"Datta-Mannan","year":"2020","journal-title":"MAbs"},{"key":"10.1016\/j.jconrel.2025.114401_bb0035","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1007\/s11095-016-1900-x","article-title":"In silico modelling of transdermal and systemic kinetics of topically applied solutes\u00a0: model development and initial validation for transdermal nicotine","author":"Chen","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2025.114401_bb0040","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2352887","article-title":"Predicting the clinical subcutaneous absorption rate constant of monoclonal antibodies using only the primary sequence: a machine learning approach","volume":"16","author":"Bei","year":"2024","journal-title":"MAbs"},{"key":"10.1016\/j.jconrel.2025.114401_bb0045","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1124\/dmd.114.059121","article-title":"Pharmacokinetic modeling of the subcutaneous absorption of therapeutic proteins","volume":"42","author":"Kagan","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2025.114401_bb0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1208\/s12248-015-9819-4","article-title":"A bottom-up whole-body physiologically based pharmacokinetic model to mechanistically predict tissue distribution and the rate of subcutaneous absorption of therapeutic proteins","volume":"18","author":"Gill","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2025.114401_bb0055","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/clpt.2008.170","article-title":"Monoclonal antibody pharmacokinetics and pharmacodynamics","volume":"84","author":"Wang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2025.114401_bb0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13555-020-00465-w","article-title":"The microbiome in hidradenitis Suppurativa: a review","volume":"11","author":"Wark","year":"2021","journal-title":"Dermatol. Ther. (Heidelb.)"},{"key":"10.1016\/j.jconrel.2025.114401_bb0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2018.01.015","article-title":"In vitro model for predicting bioavailability of subcutaneously injected monoclonal antibodies","volume":"273","author":"Bown","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114401_bb0070","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jconrel.2025.02.022","article-title":"Predicting human subcutaneous bioavailability of monoclonal antibodies using an integrated in-vitro\/in-silico approach","volume":"380","author":"Hanafy","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114401_bb0075","first-page":"1","article-title":"A biomimetic chip to assess subcutaneous bioavailability of monoclonal antibodies in humans","volume":"2","author":"Suja","year":"2023","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.jconrel.2025.114401_bb0080","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-020-00446-z","article-title":"Subcutaneous site-of-absorption study with the monoclonal antibody tocilizumab in Minipigs: administration behind ear translates best to humans","volume":"22","author":"Richter","year":"2020","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2025.114401_bb0085","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/dmd.111.043604","article-title":"Lymphatic transport and catabolism of therapeutic proteins after subcutaneous administration to rats and dogs","volume":"40","author":"Wang","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2025.114401_bb0090","article-title":"Monoclonal antibody pharmacokinetics in Cynomolgus monkeys following subcutaneous administration: physiologically based model predictions from physiochemical properties","volume":"25","author":"Hu","year":"2023","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2025.114401_bb0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molimm.2014.10.023","article-title":"The immunology of the porcine skin and its value as a model for human skin","volume":"66","author":"Summerfield","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2025.114401_bb0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1524-475x.2001.00066.x","article-title":"The pig as a model for human wound healing","volume":"9","author":"Sullivan","year":"2001","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.jconrel.2025.114401_bb0105","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2022.2163003","article-title":"MPET2: a multi-network poroelastic and transport theory for predicting absorption of monoclonal antibodies delivered by subcutaneous injection","volume":"30","author":"Wang","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.114401_bb0110","first-page":"2353","article-title":"Imaging of large volume subcutaneous deposition using MRI: exploratory clinical study results, drug Deliv","volume":"13","author":"Pettis","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.jconrel.2025.114401_bb0115","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2337\/dc12-1319","article-title":"Enhanced absorption of insulin Aspart as the result of a dispersed injection strategy tested in a randomized trial in type 1 diabetic patients","volume":"36","author":"Mader","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jconrel.2025.114401_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1205121","article-title":"Factors affecting the absorption of subcutaneously administered insulin: effect on variability","volume":"2018","author":"Gradel","year":"2018","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.jconrel.2025.114401_bb0125","doi-asserted-by":"crossref","DOI":"10.1089\/dia.2019.0195","article-title":"Insulin distribution in human adipose tissue via a novel insulin infusion catheter","author":"Altendorfer-Kroath","year":"2019","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.jconrel.2025.114401_bb0130","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/srt.12071","article-title":"Clinical applicability of dOFM devices for dermal sampling","volume":"19","author":"Bodenlenz","year":"2013","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.jconrel.2025.114401_bb0135","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.xphs.2016.05.029","article-title":"Subcutaneous injection volume of biopharmaceuticals\u2014pushing the boundaries","volume":"105","author":"Mathaes","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114401_bb0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10928-017-9559-4","article-title":"A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim","volume":"45","author":"Niederalt","year":"2018","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.jconrel.2025.114401_bb0145","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1463-1326.2004.00410.x","article-title":"Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia, diabetes","volume":"7","author":"Farvid","year":"2005","journal-title":"Obes. Metab."},{"key":"10.1016\/j.jconrel.2025.114401_bb0150","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00592-003-0076-0","article-title":"Body fat in adult man: Semicentenary of fat density and skinfolds","volume":"40","author":"Fidanza","year":"2003","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.jconrel.2025.114401_bb0155","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s11095-023-03499-9","article-title":"A comparative analysis of biological and synthetic skin models for drug transport studies","volume":"40","author":"Biondo","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2025.114401_bb0160","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s10237-022-01622-0","article-title":"Mixed - dimensional multi - scale poroelastic modeling of adipose tissue for subcutaneous injection","volume":"21","author":"Leng","year":"2022","journal-title":"Biomech. Model. Mechanobiol."},{"key":"10.1016\/j.jconrel.2025.114401_bb0165","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00441-019-03108-5","article-title":"Lymphatic vessels in human adipose tissue","volume":"379","author":"Redondo","year":"2020","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.jconrel.2025.114401_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.1061178","article-title":"Dermal open flow microperfusion for PK-based clinical bioequivalence studies of topical drug products","volume":"13","author":"Birngruber","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.114401_bb0175","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijpharm.2018.04.013","article-title":"Qualitative and quantitative analysis of lateral diffusion of drugs in human skin","volume":"544","author":"Nguyen","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114401_bb0180","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s11095-016-1991-4","article-title":"Large size microneedle patch to deliver lidocaine through skin","volume":"33","author":"Kathuria","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2025.114401_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2015.07.032","article-title":"A quantitative radioluminographic imaging method for evaluating lateral diffusion rates in skin","author":"Rush","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114401_bb0190","doi-asserted-by":"crossref","DOI":"10.1159\/000076018","article-title":"Lateral diffusion of ibuprofen in human skin during permeation studies","author":"Schicksnus","year":"2004","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.jconrel.2025.114401_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4142\/jvs.2021.22.e47","article-title":"Ustekinumab pharmacokinetics after subcutaneous administration in swine model","volume":"22","author":"Grabowski","year":"2021","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.jconrel.2025.114401_bb0200","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.xphs.2019.01.015","article-title":"Impact of precipitation of antibody therapeutics after subcutaneous injection on pharmacokinetics and immunogenicity","volume":"108","author":"Kinderman","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114401_bb0205","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.xphs.2019.01.015","article-title":"Impact of precipitation of antibody therapeutics after subcutaneous injection on pharmacokinetics and immunogenicity","volume":"108","author":"Kinderman","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114401_bb0210","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10928-016-9482-0","article-title":"Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies","volume":"43","author":"Glassman","year":"2016","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.jconrel.2025.114401_bb0215","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10928-020-09691-3","article-title":"Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling","volume":"47","author":"Hu","year":"2020","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.jconrel.2025.114401_bb0220","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1124\/dmd.114.059121","article-title":"Pharmacokinetic modeling of the subcutaneous absorption of therapeutic proteins","volume":"42","author":"Kagan","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2025.114401_bb0225","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4161\/mabs.26008","article-title":"Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics","volume":"5","author":"Golay","year":"2013","journal-title":"MAbs"},{"key":"10.1016\/j.jconrel.2025.114401_bb0230","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ejpb.2007.04.009","article-title":"Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets","volume":"67","author":"Garg","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.114401_bb0235","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4155\/tde.11.31","article-title":"Electrostatic interactions of monoclonal antibodies with subcutaneous tissue","volume":"2","author":"Mach","year":"2011","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2025.114401_bb0240","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2020.1770028","article-title":"Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies","volume":"12","author":"Datta-Mannan","year":"2020","journal-title":"MAbs"},{"key":"10.1016\/j.jconrel.2025.114401_bb0245","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/antib13030070","article-title":"A physiologically based pharmacokinetic model relates the subcutaneous bioavailability of monoclonal antibodies to the saturation of FcRn-mediated recycling in injection-site-draining lymph nodes","volume":"13","author":"Stader","year":"2024","journal-title":"Antibodies"},{"key":"10.1016\/j.jconrel.2025.114401_bb0250","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.xphs.2024.02.004","article-title":"Assessing physicochemical stability of monoclonal antibodies in a simulated subcutaneous environment","volume":"113","author":"Jogdeo","year":"2024","journal-title":"J. Pharm. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925010156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925010156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:41:19Z","timestamp":1781325679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925010156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":50,"alternative-id":["S0168365925010156"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114401","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting human subcutaneous bioavailability of monoclonal antibodies using an open flow microperfusion porcine model","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114401","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114401"}}